project id: TCGA-UCEC; case submitter id: TCGA-AJ-A2QO; source center: 23; state: released; a260 a280 ratio: 1.75; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.4; rna integrity number: 8.1; age at index: 85; days to birth: -31222; days to death: 1045; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1926; age at diagnosis: 31222; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 92.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 174; days to sample procurement: 0; initial weight: 16.0; portion submitter id: TCGA-AJ-A2QO-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 15.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 55.0; percent tumor nuclei: 65.0;